Related by context. All words. (Click for frequent words.) 80 Announces FDA Clearance 77 Receives FDA Clearance 75 Obtains FDA 75 Receives CE Marking 74 Receives Orphan Drug Designation 74 FDA Clears 74 received CE Conformité 73 Gets FDA Clearance 73 Completes Patient Enrollment 73 Completes Enrollment 73 Announce License Agreement 72 Initiates Enrollment 72 Receives Regulatory 72 Files IND 72 FDA Approvals 71 Obtains CE Mark 71 Receives Patent 70 Initiates Clinical Trial 70 Enrolls First 70 Receives Approvable Letter 70 liver resection surgeries 70 Sign Licensing Agreement 70 Granted Orphan Drug 69 FDA Okays 69 FDA Approves 69 Demonstrates Significant 69 Submits NDA 69 TM Everolimus Eluting 69 FDA Accepts 69 Awarded Patent 69 Introduces Revolutionary 69 Initiates Clinical Trials 69 FDA Clearance 69 Expanded Indication 69 Drug Eluting Coronary Stent 68 Demonstrates Positive 68 Meets Primary Endpoint 68 Drug Eluting Stent 68 Announces Initiation 68 ™ Everolimus Eluting 68 Files Patent Application 68 Announce Collaboration Agreement 68 Presents Positive 68 Initiates Phase II 68 TAXUS Element Paclitaxel Eluting 67 k Clearance 67 Non Invasive 67 Announces Tentative Approval 67 PROMUS R 67 Taro Receives 67 Initiates Clinical 67 Receives Fast Track 67 Receives Milestone Payment 67 IND Application 67 received CE Conformite 67 injectable bulking agent 67 INTELLITEMP ® 67 Receives Positive 67 Sign License Agreement 67 Vitrasert R 67 Vascular Grafts 67 Microwave Ablation System 67 ORLive Presents 66 Liberte TM 66 Uracyst R Test 66 Submits Biologics License Application 66 PROMUS TM 66 First Patient Treated 66 Patient Enrollment 66 Develop Novel 66 Improves Survival 66 Significantly Reduces 66 Receives Orphan Drug 66 Announces License Agreement 66 NDA Submission 66 Signs Licensing Agreement 66 Announce Merger Agreement 66 Vascular Closure Device 66 Boucher Albie Morkel 66 Mylan Receives Approval 66 Begins Shipment 66 Phase III Clinical Trial 66 Cypher Sirolimus 66 Pivotal Trial 65 Receives Positive Opinion 65 Present Preclinical Data 65 Receives ISO #:# [002] 65 Therapeutic Competitors Companies 65 Reconstructive Tissue Matrix 65 Reveals Positive 65 Awarded Qualifying Therapeutic 65 Pivotal Study 65 PATHFINDER R 65 Announces Licensing Agreement 65 Commences Phase 65 Clinical Trial Results 65 TM Drug Eluting 65 Introduces Next Generation 65 Announces Positive 65 TM Embolic Protection 65 Absorbable 65 Initiates Phase III 65 vapreotide acetate 65 Improves Outcomes 65 Receives Conditional 65 FDA Approval 65 Clinical Trial Evaluating 65 IND Filing 65 Single Dose 65 Receives Notice 65 PATHFINDER ® TRACER 65 Submits Application 65 Prostate Cancer Vaccine 65 Reports Positive 64 Announces Immediate Availability 64 Clinical Study Shows 64 Custom NX R 64 Study Evaluating 64 Begins Clinical Trial 64 Drug Eluting Stent System 64 Vascular Graft 64 Generic Versions 64 Patients Undergoing 64 visit www.dobimedical.com 64 Pivotal Clinical Trial 64 Pivotal Phase III 64 Submits Response 64 Announce Licensing Agreement 64 Announces Successful Completion 64 Less Invasive 64 Drug Candidate 64 Xcytrin R 64 Trial Evaluating 64 Regains Compliance 64 Receives ONC ATCB 64 Receives Favorable 64 Presents Preclinical Data 64 Investigational Treatment 64 BioSante Pharmaceuticals Announces 64 Receives Marketing Authorization 64 Varicose Vein Treatment 64 Shows Promising 64 Launches Next Generation 64 Achieves ISO # 64 Phase IIb Trial 64 Patients Enrolled 64 Antimicrobial Coating 64 endoscopic autofluorescence imaging 64 Initiate Clinical Trial 64 Announces Rebranding 64 Shows Statistically Significant 64 Receives SFDA Approval 64 Receives Tentative FDA 64 Eluting Coronary Stent System 64 Receives NASDAQ 64 Self Expanding Stent 64 Thoracic Endoprosthesis 64 Generic Version 64 Receives Tentative Approval 64 Achieves Milestone 64 lead molecular radiotherapeutic 64 REMINDER ORLive Presents 64 Begins Dosing 64 Embolic 63 Misonix Announces 63 Announces Issuance 63 Patent Issued 63 Provides Update Regarding 63 Issued Patent 63 TRANSDUR ® 63 3M Completes Acquisition 63 NAVISTAR R 63 Prolongs Survival 63 Sinks Lower 63 NAVIPORT ® Series 63 Study Demonstrates 63 Complicated Skin 63 Begins Shipping 63 Receives Notification 63 Significantly Improves 63 Verisyse TM intraocular lenses 63 Dry Powder Inhaler 63 Investigational Oral 63 Introduces Novel 63 Licenses Novel 63 Achieves Primary Endpoint 63 topically applied SEPA 63 Thrombectomy System 63 PRN FDA Approves 63 Regains NASDAQ 63 candidates Azedra 63 Phase 2b Clinical Trial 63 Release Capsules 63 Severe Sepsis 63 Proven Effective 63 Receives Approval 63 First Patient Enrolled 63 Subsidiary Enters 63 Conformite Europeenne CE 63 Introduces Enhanced 63 CE Marked 63 Nasdaq SMTS develops manufactures 63 Strengthens Position 63 Surgical Sealant 63 Embolic Protection 63 INTELLITEMP ® Energy 63 Receives FIPS #-# 63 ™ Paclitaxel Eluting 63 Announces Addition 63 Receives Clearance 63 Launches Generic Version 63 TM Aganocide 63 Presents Positive Preclinical 63 Unveils Revolutionary 63 Mitral Valve Repair 63 Cerebral Somatic Oximeter 63 Voluntarily Withdraws 63 AnaSpec Introduces 63 BioGlue R 63 FDA Panel Recommends 63 EndoBarrier ™ 63 Successfully Treats 63 Announce Receipt 63 Amends Agreement 63 Balloon Catheters 63 Signs License Agreement 63 Bone Graft 63 Jointly Announce 63 Non Invasive Treatment 63 Submits IND 63 Secures Patent 63 Tecnis R 63 Patent Covering 63 Extends Collaboration 63 Biliary System 63 Obtains Approval 63 AMPLATZER R 63 Shows Promise 63 Files Investigational 63 Announce Expiration 63 Wins Patent Infringement 63 Initiates Dosing 63 Psoriasis Drug 63 Releases Next Generation 63 Phase IIb Clinical Trial 63 Receives Complete Response 63 Announces Publication 63 Sagent Pharmaceuticals Announces 63 Commercializes 63 Robotic Catheter 63 Effectively Treats 62 CryoSeal FS System 62 REVELATION ® Series 62 Settle Patent Litigation 62 Receives ISO #:# [001] 62 SABER ™ 62 Submits Supplemental 62 Named Exclusive Distributor 62 Signs Merger Agreement 62 Awarded Patents 62 markets COLAZAL 62 Introduces Breakthrough 62 Adjuvant Treatment 62 Achieves Prestigious 62 Wound Dressing 62 Announces Receipt 62 Announces Termination 62 Reduces Pain 62 Balloon Catheter 62 Regains Compliance With 62 Receives Unsolicited 62 PROMUS Element 62 Reduces Risk 62 Contrast Agent 62 Confirms Efficacy 62 Drug Fails 62 miconazole Lauriad R 62 Endologix Powerlink System 62 NeutroPhase TM 62 REVELATION ® 62 Successfully Tested 62 Embolic Protection System 62 Immunomedics Announces 62 Taglich Brothers Initiates Coverage 62 candidates Azedra TM 62 VIVUS Announces 62 Proves Successful 62 Therapy RecoveryRx TM 62 Jumps Higher 62 TRANSDUR ™ 62 Bioresorbable 62 Carotid Stent 62 Previously Untreated 62 Patients Treated With 62 Minimally Invasive Procedure 62 Initiates Phase 62 Augment TM 62 Earns Milestone Payment 62 Syneron logo 62 Surgical Mesh 62 Commence Phase 62 Tumor Targeting 62 Reports Receipt 62 Further Validates 62 Avon Naturals 62 pericardial closure 62 Acute Attacks 62 Achieves SAS 62 Prophylactic Treatment 62 Announces Successful 62 Glaucoma Treatment 62 urethral bulking agent 62 Shows Promise Against 62 Completes Tender Offer 62 VUEPORT ® 62 ALVESCO ® 62 endoluminal stent graft 62 Trobalt 62 Inhalation Aerosol 62 Identifies Potential 62 Announces Poster Presentations 62 Spinal Elements 62 Européenne Mark 62 Files Patent 62 Enters Into Exclusive 62 Grants Orphan Drug 62 Vacuum Assisted Closure 62 Aneurysm Repair 62 Retisert ® 62 Successfully Completes Phase 62 Strengthens Its 62 Provides Shareholder 62 Successfully Completes 62 Enhances User Experience 62 includes Dideco CarboMedics 62 Patients Treated 62 ORADUR ® 62 ATS Simulus R 62 Regenerative Cells 62 Alair System 62 Image Guided 62 Receives Stockholder Approval 62 ELADUR TM 62 Acquires Exclusive 62 Controlled Study 62 Unigene nasal calcitonin 62 Drug Coated Stent 62 Obtains Exclusive License 62 Q3 Loss Widens 62 Achieves ISO 62 Excimer Laser System 62 molecular imaging radiopharmaceutical 62 Dose Ranging Study 62 Robotic Catheter System 62 Reacquires 62 PerkinElmer Acquires 62 Edwards SAPIEN 62 SPL# Gel vaginal microbicide 62 Collaborators Present 62 Announces Additions 62 Demonstrates Potential 62 Achieves Significant 62 Flagship Product 62 Launches Unique 61 Terminate Merger Agreement 61 Commercialize Novel 61 SpineAlign 61 Positive Opinion 61 Announces Presentation 61 absorbable powder hemostat 61 FDA APPROVES 61 Files Shelf Registration Statement 61 Pulmonary Valve 61 acetonide FA 61 Achieves ISO #:# Certification [002] 61 Develop Next Generation 61 Randomized Clinical Trial 61 Iluvien ® 61 Augment ™ 61 Durezol TM 61 R brand levalbuterol 61 Announces Effective Date 61 received CE Marking 61 Study Evaluates 61 Announces Stockholder Approval 61 Completes Successful 61 ReZoom TM 61 topical gel formulation 61 Terminates Contract 61 Teva Provides Update 61 benzoic acid hyoscyamine sulfate 61 Reperfusion Injury 61 Artificial Disc 61 Enters Into License Agreement 61 Percutaneous Transluminal Coronary Angioplasty 61 delivers fluocinolone acetonide FA 61 Completes Reverse Merger 61 Breast Biopsy 61 Commercialize 61 CE marked PROGENSA 61 aneurysms AAA 61 Ablation System 61 Presents Preclinical 61 Crofelemer budesonide foam 61 Provides Updates 61 Renal Artery 61 Secures Financing 61 Launches Innovative 61 2 COLOURS TM 61 Testosterone Gel 61 Miraculins Announces 61 NEBIDO VANTAS SUPPRELIN LA 61 STAR S4 IR 61 methylnaltrexone bromide 61 Patent Infringement Suit Against 61 Obtains License 61 Dural Regeneration Matrix 61 Ventricular Assist Devices 61 brand ciclesonide Nasal 61 Inc. OTCBB CADM 61 Nasdaq Listing Requirements 61 Enters Into Distribution 61 Regains Full 61 Combination REOLYSIN R 61 Endovascular Treatment 61 Metricath Gemini 61 treating abdominal aortic 61 Aztreonam Lysine 61 Oral Calcitonin 61 Tezampanel 61 Serostim ® 61 Phase III Trial 61 Emboshield 61 Gout Drug 61 BioElectronics Announces 61 NASDAQ POSS 61 Patient Treated 61 Stent Coating 61 Soft Tissue Sarcoma 61 SilverHawk System 61 Successfully Completed 61 #k Clearance 61 Patent Infringement Litigation 61 Peripherally Inserted Central 61 Announces Enhancements 61 Oracea ® 61 Long Term Efficacy 61 CORTOSS R 61 Spinal Implant 61 Contrast Enhanced 61 Lupus Drug 61 Cardiovascular Prosthetic Devices 61 Advanced Microspheres 61 Reports Preclinical Data 61 Eluting Stent 61 Provides Comprehensive 61 Achieves Unprecedented 61 Surgical Ablation 61 Announce Completion 61 Announces Commencement 61 Blood Thinner 61 highly purified pasteurized 61 Total Knee Arthroplasty 61 Milestone Payment 61 Source Victhom Human 61 Ondansetron Injection 61 Attains 61 Beta Blocker 61 Therapeutic Competitors Report 61 CysDisplay R 61 Further Strengthens 61 Significantly Improved 61 Rheumatoid Arthritis Drug 61 Announce Definitive Agreement 61 Spinal Fusion 61 Treatment Naïve 61 Arthritis Drug 61 Hematology Molecular Pathology 61 Unveils Groundbreaking 61 Drug Shows Promise 61 refractory recurrent 61 R famotidine 61 Boucher Nicky Boje 61 NASH Huntington 61 Dementia Related Psychosis 61 Obtains Regulatory 61 Microcatheter 61 R lenalidomide 61 PROMUS ® 61 Microdermabrasion Chemical Peels Collagen 61 Niris Imaging System 60 Peripheral Stent 60 topical non steroidal 60 robust interlibrary loan 60 delivers preprogrammed intermittent 60 Pancreatic Adenocarcinoma 60 Secondary Hyperparathyroidism 60 Platinum Chromium 60 BIOLASE Announces 60 Q2 Loss Narrows 60 Completes Initial 60 ® Advanced CustomVue 60 Regains Nasdaq 60 Prospective Randomized 60 Announces Cancellation 60 Left Atrial Appendage 60 Surgical Adhesive 60 Launches Enhanced 60 Completes Merger 60 Mg Usa 60 NASDAQ BSMD medical 60 Desvenlafaxine Succinate 60 Receives Approvals 60 Receives Certification 60 Completes Patient Enrolment 60 Enters Into Licensing Agreement 60 Wafer polifeprosan 60 Ciclopirox 60 Files Registration Statement 60 R Therapy RecoveryRx 60 Voluntarily Withdraw 60 About TenFold TenFold 60 Investigational Compound 60 Announce Successful Completion 60 R Saizen R 60 HeartWare System 60 researches develops licenses 60 Pharmaceuticals Initiates 60 automated radiopharmaceutical distribution 60 HeartMate R 60 Tyrosine Kinase Inhibitor 60 Transdermal Patch 60 Phase IIa Clinical Trial 60 Unveils Next Generation 60 FY# Loss Widens 60 Endometrial Ablation 60 Scott Regan Sonoa 60 Acquire Controlling Interest 60 WorldHeart Announces 60 Integra LifeSciences Announces 60 Shareholders Approve Acquisition 60 Plaque Psoriasis 60 Implantable Device 60 Q4 Loss Widens 60 Expands Capabilities 60 Initiate Phase III 60 Announce Collaboration 60 ELADUR ™ 60 Novel Oral 60 Low Dose 60 Sirolimus eluting Coronary Stent 60 Successfully Closes 60 Confirms Receipt 60 Phase 2a Trial 60 Generic Version Of 60 Fibrin Sealant 60 PROMUS Element Everolimus Eluting 60 Intravenous Human 60 Q1 Loss Narrows 60 Endovascular System 60 Completes Dosing 60 Cobalt Chromium 60 Study Showed 60 Cardium Therapeutics TM 60 Phase 2b Trial 60 Treatment Reduces 60 platform HDL Mimetic 60 Cardioblate 60 Announcement acc 60 Infusion Pumps 60 Chisholm Sam Cordingley 60 JAK2 Inhibitor 60 PDUFA Date 60 ® VAD Ventricular 60 Axxent R 60 Settle Patent Dispute 60 Significantly Enhances 60 Delivers Next Generation 60 Loceryl ® 60 Achieves Certification 60 Provide Comprehensive 60 AllPennyStocks.com Spotlights 60 Announces Completion 60 Thrombectomy 60 Regenerative Cell 60 Vertebral Body Replacement 60 lexidronam injection 60 Devices HealFast TM 60 Announces Preliminary 60 Commences Trading 60 Announces Expanded 60 FDA Warns 60 Expands Functionality 60 Sirolimus Eluting Stent 60 REVELATION Helix 60 Endurant 60 Introduces Innovative 60 novel orally inhaled 60 Staphylococcus aureus Immune Globulin 60 Announces Underwriters Exercise 60 BCG refractory carcinoma 60 STARFlex R 60 selective A2A adenosine receptor 60 MRI Patient Monitoring 60 Unveils Innovative 60 Demonstrates Long Term 60 treat atrial flutter 60 Completes Merger With 60 REPRONEX R menotropins 60 Diabetic Patients 60 Receives Conditional Approval 60 Heart Transplant Recipients 60 Oral Mist 60 Powerlink ® 60 Announces Launch 60 Nicotine Vaccine 60 Transdermal System 60 Medical Sorin Biomedica 60 Molecular Diagnostic Test 60 Win GoodNites ® 60 Subsidiary Receives 60 Preclinical Data 60 Forward Looking IVUS 60 coronary stent merged 60 FACTIVE ® 60 Receive Milestone Payment 60 Earns ISO #:# 60 Successfully Completes Tender Offer 60 Cholesterol Lowering Drug 60 Intravascular 60 Immunoassay Systems 60 Sign Definitive Merger 60 ATS 3f Enable 60 treat seborrheic dermatitis 60 Announce Availability 60 DIURIL R 60 Commercially Available 60 Patents Covering 60 Obtains Exclusive Rights 60 COLAZAL ® 60 brand ciclesonide HFA 60 Coronary Stent System 60 Gliadel R 60 Recombinant Human 60 REG1 Anticoagulation System 60 Epi LASIK 60 Rejects Unsolicited 60 FDA Approvable Letter 60 Discontinues 60 http:/www.Send2Press.com SOURCE 60 Finalizes Acquisition 60 Receives Confirmation 60 Alcortin TM 60 Amvisc Plus TM 60 Personalized Immunotherapy 60 Expands Portfolio 60 Enters Into Agreement 60 OMAPRO ™ 60 Proves Effective 60 Therapy Improves 60 Paclitaxel Eluting 60 Receives Funding 60 Novel Compound 60 Veeco Introduces 60 Novartis Trileptal 60 successfully commercialize Iluvien 60 PINPOINT TM System 60 Previously Treated 60 Compression Therapy 60 label Lipofen R 60 Successfully Tests 60 Announces Definitive Merger 60 Enters Agreement 60 Extends Expiration Date 60 phenyl salicylate methylene blue 59 Announce Licensing 59 CMDCAS 59 MSON 59 Everolimus Eluting Coronary Stent 59 Updates Status 59 Baerveldt R 59 Successful Completion 59 Advanced Melanoma 59 Updates Shareholders 59 proprietary intranasal insulin 59 Healon ® viscoelastics 59 therefore therapeutically equivalent 59 Successfully Treated 59 CoreSpine Technologies 59 Ultrasonic Wound 59 Provides Guidance 59 Announces Signing 59 Tissue Engineered 59 Combination Treatment 59 Aloprim TM allopurinol sodium 59 Breakthroughstocks.net EXPLOSIVE news 59 Systemic Delivery 59 External Beam 59 Annuloplasty 59 Shows Efficacy 59 Anterior Cervical Plate 59 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 59 mechanical thrombectomy 59 Silicone Breast Implants 59 Conformite Europeene CE 59 Closes Merger 59 XIENCE PRIME TM 59 MONSTERSTOX.COM Monsterstox.com 59 Tissue Repair 59 Numoisyn Liquid 59 Medtronic CoreValve ® 59 Boosts Productivity 59 Closes Second Tranche 59 Announces Divestiture 59 Significantly Increases 59 Obtains Patent 59 Mg Uk 59 Announces Intent 59 include Phenoptin TM 59 VISICOL R 59 Successfully Completes Acquisition 59 Recommends Approval 59 Adagen ® 59 Fungal Infections 59 Oral Spray 59 Drug Eluting 59 Settles Patent Dispute 59 Replacement Therapy 59 Phase 2b Study 59 Initiate Phase 59 Oral Mucositis 59 Osteoporosis Drug 59 NASDAQ IMDC 59 Board Unanimously Rejects 59 Neoadjuvant Chemotherapy 59 Submits Investigational 59 Anterior Cervical 59 ATRA IV 59 Adjunctive Therapy 59 ROTATEQ ® 59 Strengthens Balance Sheet 59 Increases Ownership 59 IMPACS R 59 Develops Novel 59 Announces Filing 59 Announce Interoperability 59 MOVIPREP R 59 Heart Failure Patients 59 Acquires Assets 59 Enters Into Strategic 59 cardiometabolic diseases Glucophage 59 Q3 Loss Narrows 59 Phase 2a Clinical Trial 59 Announces Shareholder Approval 59 Tambocor 59 Cardiac Resynchronization Therapy 59 Derma Sciences Announces 59 GTC recombinant form 59 operating subsidiary CytoSorbents 59 Kristalose ® lactulose 59 Announces Definitive Agreement 59 Vascular Wrap TM 59 Zicam Cold Remedy RapidMelts 59 Invasive Fungal Infections 59 STERIS Corporation Announces 59 Earns Coveted 59 Successfully Demonstrates 59 Anticancer Drug 59 Endeavor Drug Eluting 59 Secures Additional 59 Talent Abdominal 59 Motorola Invests 59 Control Catheter 59 Provides Clarification 59 Adhesion Barrier 59 Breast Cancer Recurrence 59 ® brand arformoterol 59 Single Incision 59 OTCBB TDLP 59 AtriCure Isolator 59 Interbody 59 Chisholm James Horwill 59 Completes Previously Announced 59 Inks Distribution 59 Robot Assisted 59 Improve Survival 59 Topical Treatment 59 Acquires Controlling Interest 59 Clinical Outcome 59 Schizophrenia Drug 59 visit www.genenews.com 59 Revolutionizes 59 Sign Definitive Agreement 59 Metered Dose Inhaler Devices 59 Nasopharyngeal Electrodes Needle Electrodes 59 Successfully Launches 59 Announces Voluntary Recall 59 Q2 Loss Widens 59 SIX RO ROG 59 Chronic Hepatitis C 59 equine osteoarthritis marketed 59 Study Shows Benefits 59 Releases Enhanced 59 Mutually Agree 59 Prostate Cancer Treatment 59 Being Studied 59 Closes Previously Announced 59 Expands Internationally 59 Heart Stents 59 paclitaxel eluting 59 Receives Shareholder Approval 59 Voluntarily Recalls 59 Secures Funding 59 Intraocular Lens 59 Juvederm ™ 59 Receives Notice From 59 Dynamic Stabilization 59 PROCTOCORT R 59 INVOS R 59 Restructures Debt 59 Obtains 59 Results Confirm 59 Appoints Experienced 59 CHEAP ONLINE PHARMACY LOW 59 Endovascular Graft 59 Blood Pressure Drug 59 Transdermal Drug 59 Peripheral Arterial 59 FREMONT CA #/#/# 59 Finalizes Purchase 59 HA viscoelastic products 59 Lowers Risk 59 pralatrexate injection folate analogue 59 Clinical Study 59 Begin Clinical Trials 59 Study Validates 59 Evoclin R 59 Surfactant Technology 59 SpideRX 59 Hydrochlorothiazide Tablets 59 Equipment Deals 59 Pharma Merck Serono 59 Sirolimus eluting 59 TM Devices HealFast 59 Completes Asset 59 XIENCE V Everolimus Eluting 59 FUSILEV ® 59 Monotherapy 59 HCl Tablets 59 Announces Proposed 59 Fludara ® 59 AGREEMENTS SOURCE 59 Exemption IDE approval 59 Completes Installation 59 Adjuvant Chemotherapy 59 oral dual endothelin 59 Pedicle Screw System 59 Completes Purchase 59 Signs Distribution 59 Nasdaq MSON designs 59 Inhaled Insulin 59 David Rapperport Quest 59 HydroFix 59 Investigational Agent 59 METOZOLV TM ODT metoclopramide 59 Small Molecule 59 Enlarged Prostate 59 Therapeutic Catheters Rapid 59 Could Detect 59 Pulse Oximetry 59 Improves Patient 59 TNF Tumor Necrosis Factor 59 S. Quigley mquigley@ncd.gov 59 Aortic Valve Replacement 59 vinorelbine tartrate 59 Receives Authorization 59 Treatment Regimen 59 MetroGel 59 Optical Biopsy System 59 Alair Bronchial Thermoplasty System 59 Hernia Repair 59 product ProBiora3 59 R Paclitaxel Eluting 59 Epilepsy Drug 59 Enters Into Definitive Agreement 59 clobetasol propionate Foam 59 Completes Financing 59 Transcatheter 59 manufactures minimally invasive 59 PEEK OPTIMA ® 59 INDUSTRY ASSESSMENTS 59 Advanced Colorectal Cancer 59 Jones WR KR 59 MarrowXpress 59 Combination Therapy 59 Announce Expanded 59 Initiates Phase 2b 59 Demonstrates Sustained 59 TriActiv R 59 Aortic Valve 59 Expand Collaboration 58 Bush Embraces Pause 58 Signs Agreements 58 Pediatric Patients 58 Announce Early Termination 58 ® EBLY ® MASTERFOODS 58 Boucher Morne Morkel 58 Paris IPN Euronext 58 Recall Issued 58 Launches Redesigned Website 58 Levoleucovorin 58 Balloon Angioplasty 58 Oximeter 58 Completes Reorganization 58 Storage Made Simple 58 Distribution Pact 58 Vaccine Adjuvant 58 Novel Antibiotic 58 Vanderhoff Staff Writer 58 Diabetic Foot Ulcer 58 Pivotal Phase 58 Supplemental Biologics License Application 58 Fraxel ® 58 TearLab TM 58 Delivers Breakthrough 58 Marketing Authorisation Application 58 Plus STAARVISC TM 58 COLAZAL R 58 stent DES 58 Anti Tumor Activity 58 Thrombus Aspiration 58 Post Operative 58 Spectrum Pharmaceuticals Announces 58 Nasdaq CPTS developer 58 II Clinical Trial 58 Pooled Analysis 58 Announces Effectiveness 58 MicroThermX Microwave Ablation System 58 Achieves Positive 58 Coronary Stent 58 Bradmer Pharmaceuticals 58 ® ranolazine extended 58 METOZOLV ™ ODT metoclopramide 58 delivery polymer matrix 58 Distal Radius 58 Jointly Developed 58 VIVITROL ® 58 Inc Therapeutic Competitors 58 Dry Powder Inhalers 58 ST Elevation Myocardial 58 markets XIFAXAN ® 58 Advanced Signal Processing 58 Cetaphil R 58 Inhaled Nitric Oxide 58 Settles Litigation 58 Evalve MitraClip R 58 developing Bicifadine serotonin 58 Study Indicates 58 Ondansetron Orally Disintegrating Tablets 58 Postmenopausal Women 58 Metformin HCl 58 HCl PEPCID ® famotidine 58 Clinical Evaluation 58 Auto Injector 58 capromab pendetide kit 58 NexMed Receives 58 Slows Progression 58 Enters Into Definitive 58 Intravenous Formulation 58 Reports Profitable 58 Flamel Technologies Announces 58 TR Donohue 58 ENLIGHT 58 Interspinous 58 Terminates Agreement 58 SYNERGY Stent 58 signal detection CTSD 58 Jointly Offer 58 Updates Guidance 58 Preliminary Injunction Against 58 Settles Patent Litigation 58 Intravitreal 58 INTELLITEMP 58 Licenses Patents 58 Myocardial Perfusion Imaging 58 Announces Postponement 58 Acquire Remaining Shares 58 Signs Reseller Agreement 58 folgenden Meldung ist nicht 58 personalized cellular immunotherapy 58 Insulin Pen 58 Abdominal Stent Graft 58 ATS CryoMaze TM 58 ANDA Filing 58 Issues Clarification 58 Resolves Dispute 58 Transdermal Delivery 58 Daytradersdigest.com 58 Lumbar Interbody Fusion